Anti-NINJ2 monoclonal antibody

Pre-made anti-NINJ2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to NINJ2/NINJ2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1267-Ab-1/ GM-Tg-hg-IP1267-Ab-2Anti-Human NINJ2 monoclonal antibodyHuman
GM-Tg-rg-IP1267-Ab-1/ GM-Tg-rg-IP1267-Ab-2Anti-Rat NINJ2 monoclonal antibodyRat
GM-Tg-mg-IP1267-Ab-1/ GM-Tg-mg-IP1267-Ab-2Anti-Mouse NINJ2 monoclonal antibodyMouse
GM-Tg-cynog-IP1267-Ab-1/ GM-Tg-cynog-IP1267-Ab-2Anti-Cynomolgus/ Rhesus macaque NINJ2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1267-Ab-1/ GM-Tg-felg-IP1267-Ab-2Anti-Feline NINJ2 monoclonal antibodyFeline
GM-Tg-cang-IP1267-Ab-1/ GM-Tg-cang-IP1267-Ab-2Anti-Canine NINJ2 monoclonal antibodyCanine
GM-Tg-bovg-IP1267-Ab-1/ GM-Tg-bovg-IP1267-Ab-2Anti-Bovine NINJ2 monoclonal antibodyBovine
GM-Tg-equg-IP1267-Ab-1/ GM-Tg-equg-IP1267-Ab-2Anti-Equine NINJ2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1267-Ab-1/ GM-Tg-hg-IP1267-Ab-2; GM-Tg-rg-IP1267-Ab-1/ GM-Tg-rg-IP1267-Ab-2;
GM-Tg-mg-IP1267-Ab-1/ GM-Tg-mg-IP1267-Ab-2; GM-Tg-cynog-IP1267-Ab-1/ GM-Tg-cynog-IP1267-Ab-2;
GM-Tg-felg-IP1267-Ab-1/ GM-Tg-felg-IP1267-Ab-2; GM-Tg-cang-IP1267-Ab-1/ GM-Tg-cang-IP1267-Ab-2;
GM-Tg-bovg-IP1267-Ab-1/ GM-Tg-bovg-IP1267-Ab-2; GM-Tg-equg-IP1267-Ab-1/ GM-Tg-equg-IP1267-Ab-2
Products NameAnti-NINJ2 monoclonal antibody
Formatmab
Target NameNINJ2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-NINJ2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1267-Ag-1Recombinant multi-species NINJ2 protein
    ORF Viral VectorpGMLP004694human NINJ2 Lentivirus plasmid
    ORF Viral VectorvGMLP004694human NINJ2 Lentivirus particle
    ORF Viral VectorpGMLPm004671mouse Ninj2 Lentivirus plasmid
    ORF Viral VectorvGMLPm004671mouse Ninj2 Lentivirus particle


    Target information

    Target IDGM-IP1267
    Target NameNINJ2
    Gene ID4815,29862,59115,706368,611886,101097073,509556,100056783
    Gene Symbol and SynonymsNINJ2
    Uniprot AccessionQ9NZG7,Q9JHE8
    Uniprot Entry NameNINJ2_HUMAN,NINJ2_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000171840
    Target ClassificationN/A

    The target: NINJ2, gene name: NINJ2, also named as . The protein encoded by this gene belongs to the ninjurin (for nerve injury induced) family. It is a cell surface adhesion protein that is upregulated in Schwann cells surrounding the distal segment of injured nerve, and promotes neurite outgrowth, thus may have a role in nerve regeneration after nerve injury. [provided by RefSeq, Oct 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.